Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers
Clinical trial NCT01929226 · COMPLETED
Trial details
- NCT number
- NCT01929226
- Sponsor
- Elusys Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-09
- Primary completion
- 2013-11-29
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.